depression
Study Links Maternal Mental Illness-Related Variants to Perinatal Risk Factors For Offspring
Researchers identified relationships between pregnancy-related maternal traits and behaviors and polygenic risk scores for half a dozen mental health conditions.
Gut Microbiome Characteristics Tied to Depressive Symptoms in New Studies
Researchers profiled gut microbial community patterns in antidepressant-free individuals, identifying features linked to depressive symptoms.
Avera Health Publishes Clinical Validation of PGx Panel for Depression Treatment Optimization
Premium
The GeneFolio Pharmacogenomic Panel was developed by the Avera Institute for Human Genetics, a laboratory at the Sioux Falls, South Dakota-based health system.
Genetika+ Snags CE Mark for Major Depressive Disorder Drug-Matching Test
The NeuroKaire test predicts a patient's drug response by combining patient-reported information, pharmacogenetics data, and so-called "brain-in-a-dish" functional testing.
The company wants to commercialize its first antidepressant-matching service in 2023 and is hoping to launch it as an LDT in the US.